Trial Management STREAM

  1. Accelerate Your Data With Our Co-Located Clinic And Lab 12/19/2023

    Watch as we take your fresh sample from our clinic to PBMC separation. This video overviews our optimized workflows that ensure timely processing, transport, and analysis of your samples.

  2. Applying Virtual Approaches To Dermatology Trials

    Explore how to integrate virtual approaches into the design and delivery of dermatology trials – to mitigate study risks and enhance patient engagement.

  3. Secrets To A Collaborative Model To Improve TMF Management 10/30/2023

    Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.

  4. Think U.S.A.: The Operations Behind Your Clinical Trials 1/22/2025

    Ready to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.

  5. Exploring The Principles Integral To Rare Disease Drug Development 6/12/2024

    This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.

  6. Are Resource Constraints Impacting Your TMF Health? 8/22/2023

    Looking to quickly expand internal TMF resources with our anytime, anywhere TMF expertise? Unlock the potential to seamlessly access specialized TMF knowledge and support by viewing this presentation.

  7. The Path Forward, Altasciences' Approach To Project Management 3/19/2024

    Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.

  8. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  9. Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites 3/12/2021

    Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.

  10. Why Disclosure Assessments Are The First Step To Improvement 1/8/2019

    Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.